Migration of allosensitizing donor myeloid dendritic cells into recipients after liver transplantation

Liver Transplantation

Volumn 16, Issue 1, 2010, Pages 12-22

  Bosma, Brenda M ^a   Metselaar, Herold J ^a   Gerrits, Jeroen H ^a   Van Besouw, Nicole M ^a   Mancham, Shanta ^a   Groothuismink, Zwier M A ^a   Boor, Patrick P C ^a   Van Der Laan, Luc J W ^a   Tilanus, Hugo W ^a   Kuipers, Ernst J ^a   Kwekkeboom, Jaap ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ANTIBODY; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE MARROW CELL; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CHIMERA; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DONOR; GRAFT RECIPIENT; HUMAN; HUMAN CELL; KIDNEY TRANSPLANTATION; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SENSITIZATION; SPLEEN CELL; STIMULUS; T LYMPHOCYTE; TH1 CELL;

CELL MOVEMENT; CHIMERISM; CYTOKINES; DENDRITIC CELLS; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; LIPOPOLYSACCHARIDES; LIVER TRANSPLANTATION; TH1 CELLS; TRANSPLANTATION TOLERANCE;

EID: 73949140701     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21961     Document Type: Article

References (51)

1. Lechler RI, Batchelor JR. Immunogenicity of retransplanted rat kidney allografts. Effect of inducing chimerism in the first recipient and quantitative studies on immuno-suppression of the second recipient. J Exp Med 1982;156: 1835-1841.
2. Larsen CP, Morris PJ, Austyn JM. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J Exp Med 1990; 17:1307-1314.
3. Saiki T, Ezaki T, Ogawa M, Matsuno K. Trafficking of hostand donor-derived dendritic cells in rat cardiac transplantation: allosensitization in the spleen and hepatic nodes. Transplantation 2001;71:1806-1815.
4. Wang Z, Castellaneta A, De Creus A, Shufesky WJ, Morelli AE, Thomson AW. Heart, but not skin, allografts from donors lacking Flt3 ligand exhibit markedly prolonged survival time. J Immunol 2004;172:5924-5930.
5. Bishop GA, McCaughan GW. Immune activation is required for the induction of liver allograft tolerance: implications for immunosuppressive therapy. Liver Transpl 2001;7:161-172.
6. Lerut J, Sanchez-Fueyo A. An appraisal of tolerance in liver transplantation. Am J Transplant 2006;6:1774-1780.
7. Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, Ildstad S, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993;17:1127-1152.
8. Sriwatanawongsa V, Davies HS, Calne RY. The essential roles of parenchymal tissues and passenger leukocytes in the tolerance induced by liver grafting in rats. Nat Med 1995;1:428-432.
9. Sun J, Sheil R, McCaughan G, Jung S, Gallagher N, Bishop G. Strong tolerance mediated by allografting in the rat is due to donor liver leukocytes. Transplant Proc 1995; 27:3578.
10. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ, Starzl TE. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 1994;19:916-924.
11. Lu L, Woo J, Rao AS, Li Y, Watkins SC, Qian S, et al. Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med 1994;179:1823-1834.
12. Thomson AW, Lu L, Wan Y, Qian S, Larsen CP, Starzl TE. Identification of donor-derived dendritic cell progenitors in bone marrow of spontaneously tolerant liver allograft recipients. Transplantation 1995;60:1555-1559.
13. Thomson AW, Lu L. Are dendritic cells the key to liver transplant tolerance? Immunol Today 1999;20:27-32.
14. Khanna A, Morelli AE, Zhong C, Takayama T, Lu L, Thomson AW. Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo. J Immunol 2000;164:1346-1354.
15. De Creus A, Abe M, Lau AH, Hackstein H, Raimondi G, Thomson AW. Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J Immunol 2005;174: 2037-2045.
16. Rastellini C, Lu L, Ricordi C, Starzl TE, Rao AS, Thomson AW. Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 1995;60: 1366-1370.
17. Ueta H, Shi C, Miyanari N, Xu XD, Zhou S, Yamashita M, et al. Systemic transmigration of allosensitizing donor dendritic cells to host secondary lymphoid organs after rat liver transplantation. Hepatology 2008;47:1352-1362.
18. Bosma BM, Metselaar HJ, Mancham S, Boor PP, Kusters JG, Kazemier G, et al. Characterization of human liver dendritic cells in liver grafts and perfusates. Liver Transpl 2006;12:384-393.
19. van der Molen RG, Sprengers D, Binda RS, de Jong EC, Niesters HG, Kusters JG, et al. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 2004;40:738-746.
20. Mehal WZ, Juedes AE, Crispe IN. Selective retention of activated CD8+ T cells by the normal liver. J Immunol 1999;163:3202-3210.
21. Heydtmann M, Hardie D, Shields PL, Faint J, Buckley CD, Campbell JJ, et al. Detailed analysis of intrahepatic CD8 T cells in the normal and hepatitis C-infected liver reveals differences in specific populations of memory cells with distinct homing phenotypes. J Immunol 2006;177:729-738.
22. Jacob AI, Goldberg PK, Bloom N, Degenshein GA, Kozinn PJ. Endotoxin and bacteria in portal blood. Gastroenterology 1977;72:1268-1270.
23. Lumsden AB, Henderson JM, Kutner MH. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 1988;8:232-236.
24. Warle MC, Metselaar HJ, Hop WC, Gyssens IC, Kap M, Kwekkeboom J, et al. Early differentiation between rejection and infection in liver transplant patients by serum and biliary cytokine patterns. Transplantation 2003;75: 146-151.
25. van Rijen MM, Kuijf ML, Metselaar HJ, Tilanus HW, Bouma GJ, de Weger RA, et al. CD154 is expressed during treatment with calcineurin inhibitors after organ transplantation. Transplantation 2002;73:1666-1672.
26. Martinez OM, Rosen HR. Basic concepts in transplant immunology. Liver Transpl 2005;11:370-381.
27. Hilkens CM, Kalinski P, de Boer N, Kapsenberg ML. Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood 1997;90:1920-1926.
28. Goddard S, Youster J, Morgan E, Adams DH. Interleukin-10 secretion differentiates dendritic cells from human liver and skin. Am J Pathol 2004;164:511-519.
29. Bamboat ZM, Stableford JA, Plitas G, Burt BM, Nguyen HM, Welles AP, et al. Human liver dendritic cells promote T cell hyporesponsiveness. J Immunol 2009;182:1901-1911.
30. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004;5:987-995.
31. Adams AB, Williams MA, Jones TR, Shirasugi N, Durham MM, Kaech SM, et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003;111:1887-1895.
32. Valujskikh A. The challenge of inhibiting alloreactive Tcell memory. Am J Transplant 2006;6:647-651.
33. Brook MO, Wood KJ, Jones ND. The impact of memory T cells on rejection and the induction of tolerance. Transplantation 2006;82:1-9.
34. Lau AH, Thomson AW. Dendritic cells and immune regulation in the liver. Gut 2003;52:307-314.
35. Schlitt HJ, Raddatz G, Steinhoff G, Wonigeit K, Pichlmayr R. Passenger lymphocytes in human liver allografts and their potential role after transplantation. Transplantation 1993;56:951-955.
36. Mehal WZ, Azzaroli F, Crispe IN. Immunology of the healthy liver: old questions and new insights. Gastroenterology 2001;120:250-260.
37. Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology 2006;43:S54-S62.
38. Steptoe RJ, Patel RK, Subbotin VM, Thomson AW. Comparative analysis of dendritic cell density and total number in commonly transplanted organs: morphometric estimation in normal mice. Transpl Immunol 2000;8:49-56.
39. Furuhashi T, Yamaguchi Y, Wang FS, Uchino S, Okabe K, Ohshiro H, et al. Hepatic CCR7lowCD62LlowCD45RClow allograft dendritic cells migrate to the splenic red pulp in immunologically unresponsive rats. J Surg Res 2005;124: 29-37.
40. Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S, et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 2000;165:6037-6046.
41. MacDonald KP, Munster DJ, Clark GJ, Dzionek A, Schmitz J, Hart DN. Characterization of human blood dendritic cell subsets. Blood 2002;100:4512-4520.
42. Lian ZX, Okada T, He XS, Kita H, Liu YJ, Ansari AA, et al. Heterogeneity of dendritic cells in the mouse liver: identi-fication and characterization of four distinct populations. J Immunol 2003;170:2323-2330.
43. Jomantaite I, Dikopoulos N, Kroger A, Leithauser F, Hauser H, Schirmbeck R, Reimann J. Hepatic dendritic cell subsets in the mouse. Eur J Immunol 2004;34:355-365.
44. Shu SA, Lian ZX, Chuang YH, Yang GX, Moritoki Y, Comstock SS, et al. The role of CD11c(+) hepatic dendritic cells in the induction of innate immune responses. Clin Exp Immunol 2007;149:335-343.
45. Burt BM, Plitas G, Stableford JA, Nguyen HM, Bamboat ZM, Pillarisetty VG, Dematteo RP. CD11c identifies a subset of murine liver natural killer cells that responds to adenoviral hepatitis. J Leukoc Biol 2008;84:1039-1046.
46. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993;178:1041-1048.
47. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
48. Monteleone I, Platt AM, Jaensson E, Agace WW, Mowat AM. IL-10-dependent partial refractoriness to toll-like receptor stimulation modulates gut mucosal dendritic cell function. Eur J Immunol 2008;38:1533-1547.
49. Pillarisetty VG, Shah AB, Miller G, Bleier JI, DeMatteo RP. Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition. J Immunol 2004;172:1009-1017.
50. Abe M, Tokita D, Raimondi G, Thomson AW. Endotoxin modulates the capacity of CpG-activated liver myeloid DC to direct Th1-type responses. Eur J Immunol 2006;36: 2483-2493.
51. Plitas G, Burt BM, Stableford JA, Nguyen HM, Welles AP, DeMatteo RP. Dendritic cells are required for effective cross-presentation in the murine liver. Hepatology 2008; 47:1343-1351.